| Term es nes pval sidak fdr geneset_size leading_edge leading_edge_size |
| Oxidation by cytochrome p450 0.9008566567265092 2.5452584457400373 0.0109196884805464 0.998724868223808 1.0 6 P16435,O43169,Q6UW02 3 |
| Photodynamic therapyinduced nfe2l2 nrf2 survival signaling 0.9257481642598224 2.2217110157461684 0.0263028416198642 0.999999905960814 1.0 4 P07099 1 |
| Ketogenesis and ketolysis 0.8091696691868786 2.1374990942067496 0.0325574193130724 0.9999999981185382 1.0 7 P53985,P23786,O43772 3 |
| Sarscov2 and covid19 pathway 0.9003642062681961 2.1225012447009193 0.0337956682813267 0.999999999135289 1.0 4 O14786,Q8WTV0 2 |
| Heme biosynthesis 0.8471630790126298 2.0610141202363277 0.0393016930000267 0.9999999999730644 1.0 5 P22830 1 |
| Mitochondrial immune response to sarscov2 0.794191776907329 2.053184897560647 0.0400546485648733 0.9999999999832648 1.0 8 Q9H845,Q9Y6M9,Q9BQ95 3 |
| Neural crest differentiation 0.7820847682407502 1.981108589198598 0.047579097273845 0.999999999999859 1.0 9 Q9NR77 1 |
| Statin inhibition of cholesterol production 0.8258476107114487 1.9738946029167035 0.0483937285892435 0.9999999999999162 1.0 5 P37268,Q8WTV0,P35610 3 |
| Mitochondrial long chain fatty acid betaoxidation 0.7859597584303195 1.9227627408272256 0.0545098533441659 0.9999999999999984 1.0 13 P40939,Q16836,P11310,P23786,O43772 5 |
| Il10 antiinflammatory signaling pathway 0.8332005945106584 1.8551163592393536 0.0635796121650615 1.0 1.0 4 P09601 1 |
| Type i collagen synthesis in the context of osteogenesis imperfecta 0.7554265166033722 1.8067764186418775 0.0707971469224639 1.0 1.0 12 P13674,Q96AY3,Q32P28,O15460,O75718 5 |
| Omega3 omega6 fatty acid synthesis 0.7256206341437893 1.7875625896976142 0.0738466056534985 1.0 1.0 6 Q15067,O15254 2 |
| Glycerophospholipid biosynthetic pathway 0.8051490119739273 1.7414756983124569 0.0816002294149258 1.0 1.0 4 O15228 1 |
| Allograft rejection 0.7312816685484695 1.7366713231160669 0.0824452022993846 1.0 1.0 10 P08183,P49327,P04439,P01889,P42224,P10321 6 |
| Type ii interferon signaling ifng 0.7134293824377804 1.7133556678448332 0.0866471268691317 1.0 1.0 7 Q03518,P01889 2 |
| Immune response to tuberculosis 0.8581394829152431 1.6801642291405896 0.092925366968223 1.0 1.0 3 Q03518 1 |
| Mevalonate arm of cholesterol biosynthesis pathway 0.7103142658863122 1.6422989076952736 0.1005280733809965 1.0 1.0 10 Q01581,P37268,Q9BWD1 3 |
| Fatty acid betaoxidation 0.7469412427090406 1.6404355606966048 0.1009146365545321 1.0 1.0 19 P42126,P40939,O43772,Q16836,P43304,P23786,P11310 7 |
| Eicosanoid synthesis 0.8393602861049321 1.6061491102165248 0.1082411516466874 1.0 1.0 3 Q9NP80 1 |
| Srebf and mir33 in cholesterol and lipid homeostasis 0.7287678892777214 1.567853303688734 0.1169153717199442 1.0 1.0 5 Q01581,P42345 2 |
| Monoamine transport 0.8221560157905995 1.5380994095587108 0.1240243103569986 1.0 1.0 3 O15127 1 |
| Mevalonate pathway 0.718688646526368 1.5249381635768056 0.1272745218296185 1.0 1.0 5 Q9BWD1 1 |
| Mitochondrial complex iii assembly 0.6819038019439855 1.513355990272255 0.1301892575930305 1.0 1.0 10 P14927,Q9Y276,P22695,P47985,P08574,Q6DKK2,Q9UDW1 7 |
| Cholesterol biosynthesis with skeletal dysplasias 0.6618461314830887 1.4970982525181584 0.134367694403688 1.0 1.0 6 Q16850 1 |
| Vitamin b12 disorders 0.7438569656125049 1.4898006414288445 0.1362766624358771 1.0 1.0 4 Q96EY8 1 |
| Vitamin b12 metabolism 0.666094838560501 1.4786671759861565 0.1392292891617246 1.0 1.0 8 Q96EY8,Q8WTV0,P22033 3 |
| Mirna biogenesis 0.7983871004342484 1.4437860347233773 0.148799171518986 1.0 1.0 3 Q9HAV4 1 |
| Riboflavin and coq disorders 0.6475470980148927 1.431154630640899 0.1523859030764043 1.0 1.0 6 Q86YH6,Q8NFF5,Q8NI60,Q5T2R2 4 |
| Hostpathogen interaction of human coronaviruses autophagy 0.6905356504304913 1.4045014087750902 0.1601695924663957 1.0 1.0 5 O95352,P42345,Q14457 3 |
| Proteoglycan biosynthesis 0.7850434105600774 1.390732858769285 0.1643064496180408 1.0 1.0 3 Q8TB61 1 |
| Vitamin a and carotenoid metabolism 0.6824022430659656 1.3695772850083223 0.1708188943105004 1.0 1.0 5 Q8WTV0 1 |
| Insulin signaling in adipocytes diabetic condition 0.7758954528565503 1.3543356847963883 0.1756293063066181 1.0 1.0 3 P62753 1 |
| Insulin signaling in adipocytes normal condition 0.7758954528565503 1.3543356847963883 0.1756293063066181 1.0 1.0 3 P62753 1 |
| Cerebral organic acidurias including diseases 0.675995771934385 1.3420360604895576 0.1795843037116875 1.0 1.0 5 Q9H9P8 1 |
| Omega9 fatty acid synthesis 0.6228412959937538 1.316714458561092 0.187934355290853 1.0 1.0 6 O95864,P49327,O00767,O60488 4 |
| Mitochondrial complex iv assembly 0.6405467293809604 1.2872049309440623 0.1980228690396992 1.0 1.0 12 P14854,P14406,Q9Y2R0 3 |
| Factors and pathways affecting insulinlike growth factor igf1akt signaling 0.6104601519936153 1.240537425480399 0.2147766803641522 1.0 1.0 7 Q13418,Q15118,P42345,P49770 4 |
| Triacylglyceride synthesis 0.6511903795604306 1.2352073997172188 0.2167533260189318 1.0 1.0 5 Q99943,O15228 2 |
| Disorders of folate metabolism and transport 0.6105715889274629 1.2225297166102147 0.2215073732736989 1.0 1.0 8 P34897,P00374 2 |
| Ethanol effects on histone modifications 0.6240268165472491 1.2114499669156924 0.2257229991185521 1.0 1.0 12 P04818,P00374,O14929 3 |
| Tryptophan metabolism 0.6340906019419259 1.203610534131172 0.2287401460203642 1.0 1.0 15 P23381,P35610,P30084,Q02218,P40939,O94788,P51648,Q16836,Q15392 9 |
| Pparalpha pathway 0.6044858022378621 1.1943512620432808 0.232340593187204 1.0 1.0 8 P23786 1 |
| Lung fibrosis 0.5935587150490798 1.1805702018602544 0.2377735069589044 1.0 1.0 6 P09601 1 |
| Caloric restriction and aging 0.6677482906423649 1.173387766889996 0.2406403406252137 1.0 1.0 4 P43490 1 |
| Envelope proteins and their potential roles in edmd physiopathology 0.6355590421735833 1.157348637752643 0.2471299495435388 1.0 1.0 18 O94901,P61586 2 |
| Autophagy 0.6006568359041288 1.140176728184065 0.2542126808274512 1.0 1.0 10 O95352,P42345,Q14457 3 |
| Apoptosis modulation by hsp70 0.6275905955461071 1.1334781606344486 0.2570135074047013 1.0 1.0 5 P42574,P49327,P55210 3 |
| Mitochondrial complex i assembly model oxphos system 0.6620006463069169 1.122177343415121 0.2617870438289853 1.0 1.0 27 O43676,Q9H845,Q9NPL8,Q9P0J0,Q7L592,P51970,Q9Y6M9,Q96CU9,Q8N183,Q9BQ95 10 |
| Familial hyperlipidemia type 4 0.7159755950570184 1.1162450570724638 0.2643172526983164 1.0 1.0 3 Q9UBV2 1 |
| Serine metabolism 0.576800120121334 1.1026136228573158 0.2701949917289192 1.0 1.0 6 P34897,P00374 2 |
| Aryl hydrocarbon receptor pathway wp2873 0.6119708029196882 1.0662386759033806 0.2863157629305297 1.0 1.0 5 P07900,Q07812,Q15185,O00170 4 |
| Ccl18 signaling pathway 0.5814348504548918 1.033929952197106 0.3011689113276383 1.0 1.0 11 P19022,Q96GC9,Q86UE4,P42224,P27144 5 |
| Transsulfuration pathway 0.5620892186452586 1.016241598338715 0.3095143517715673 1.0 1.0 7 P25325,P23526,Q9NZL9,P26358 4 |
| Oxysterols derived from cholesterol 0.5650511686395827 1.0119898969977248 0.3115428840424779 1.0 1.0 8 O14734,O14975,Q9Y305,Q9NPJ3 4 |
| Benzoapyrene metabolism 0.8631855309218084 1.0108020844982868 0.3121111652514146 1.0 1.0 2 P07099 1 |
| Hostpathogen interaction of human coronaviruses apoptosis 0.6234676007005118 0.989716296204602 0.3223128074355943 1.0 1.0 4 P42574,P55210,Q07812 3 |
| Krebs cycle disorders 0.551986033519308 0.9874851519657936 0.3234048583621454 1.0 1.0 6 O00330 1 |
| Methionine metabolism leading to sulfur amino acids and related disorders 0.6223759817259231 0.985214664284958 0.3245186390095038 1.0 1.0 4 P23526,P55263 2 |
| Tca cycle aka krebs or citric acid cycle 0.5825961925478245 0.9524189305941064 0.3408845625125001 1.0 1.0 16 P48735,P21912,O43837,P50213,P51553 5 |
| Adipogenesis 0.5795228731593296 0.9385818557747968 0.3479454720689572 1.0 1.0 16 P49327,P14174,O75844,P42224,P43490 5 |
| Onecarbon metabolism 0.5701151659343707 0.9302243410889316 0.3522549415202705 1.0 1.0 14 P04818,P34897,P13995,P00374,P26358 5 |
| Homologous recombination 0.5427850990608318 0.9097076308296748 0.3629767188027961 1.0 1.0 8 Q9Y2S7,Q13315 2 |
| Thiamine metabolic pathways 0.6024258102116213 0.9033036538462048 0.3663647578572537 1.0 1.0 4 O14874 1 |
| Microglia pathogen phagocytosis pathway 0.5734430704552413 0.901440497779328 0.3673541572428318 1.0 1.0 5 O15143,P63000,O00443 3 |
| Folate metabolism 0.5617256382593219 0.8924021623146353 0.3721774125406289 1.0 1.0 14 P13995,Q8WTV0,P00374 3 |
| Ppar signaling pathway 0.5676750692476624 0.83581063091417 0.4032614448932854 1.0 1.0 19 O15254,Q16822,Q01469,Q15067,O60488,P23786,P11310,O14975 8 |
| Mirna regulation of p53 pathway in prostate cancer 0.5573570857332624 0.8334283388171172 0.4046031976995521 1.0 1.0 5 P42574,Q13315 2 |
| Exrna mechanism of action and biogenesis 0.8124270711785297 0.8292239595325369 0.406977689665583 1.0 1.0 2 Q9HAV4 1 |
| Robo4 and vegf signaling pathways crosstalk 0.8010501750291654 0.7895848004988579 0.4297702877394225 1.0 1.0 2 O94813 1 |
| Photodynamic therapyinduced unfolded protein response 0.5210553995193488 0.7772259874334015 0.4370254525324615 1.0 1.0 10 Q13217,P23381,Q9UBS4 3 |
| Oxidative phosphorylation 0.590980467119848 0.7634553094708514 0.4451919051939168 1.0 1.0 30 P06576,P24539,Q15904,Q86Y39,O75964,P51970,Q9Y6M9,P25705 8 |
| Nanomaterial induced apoptosis 0.506333253163165 0.7615380707368902 0.4463357485688193 1.0 1.0 7 P42574,Q14249,P49327,Q07812 4 |
| Tp53 network 0.6140916761626062 0.7229005005819844 0.4697410159854307 1.0 1.0 3 Q13315 1 |
| Nuclear receptors in lipid metabolism and toxicity 0.7730455075845974 0.6941736100966098 0.4875733402431099 1.0 1.0 2 P08183 1 |
| Influence of laminopathies on wnt signaling 0.4982507370854108 0.6925759896885103 0.4885756825448561 1.0 1.0 9 P48729,O75844,O60725 3 |
| Sarscov2 replication organelle formation 0.7710035005834227 0.6873513262345737 0.4918613621498551 1.0 1.0 2 Q14457 1 |
| Valproic acid pathway 0.4927817518046993 0.6847654274036697 0.4934919549167973 1.0 1.0 8 P40939 1 |
| Metapathway biotransformation phase i and ii 0.5545291002107886 0.684572943739872 0.4936134451636131 1.0 1.0 25 Q16850,O15217,P07099,Q6UW02,Q86UY6 5 |
| Endochondral ossification 0.4884422933673359 0.6819355105653654 0.4952797299763631 1.0 1.0 7 Q01581 1 |
| Endochondral ossification with skeletal dysplasias 0.4884422933673359 0.6819355105653654 0.4952797299763631 1.0 1.0 7 Q01581 1 |
| Alpha 6 beta 4 signaling pathway 0.5076554374983616 0.6695472451655748 0.5031464535216523 1.0 1.0 13 P61586,P11047 2 |
| Nucleotide metabolism 0.4969403738136991 0.6547980948194507 0.5125977574391065 1.0 1.0 11 P13995,P00374 2 |
| Dna damage response only atm dependent 0.518915858236349 0.6249524294206786 0.5320022801762976 1.0 1.0 19 Q16822,Q16537,P63000,P61586,Q07812,Q15118,Q13315 7 |
| Progeriaassociated lipodystrophy 0.4803660995623312 0.5992322198716392 0.5490180397835283 1.0 1.0 10 P46063,O75844 2 |
| Erk pathway in huntingtons disease 0.4935976892521191 0.5730006746895926 0.5666442371548377 1.0 1.0 5 P42858 1 |
| Eicosanoid metabolism via cyclooxygenases cox 0.4631795392896926 0.5724466719090748 0.5670194044854839 1.0 1.0 7 Q15067,O15254 2 |
| Spinal cord injury 0.5083348425136937 0.5660719190017753 0.571344891596002 1.0 1.0 20 P42574,O94813,P63000,P14174,P61586,P27695 6 |
| Eicosanoid metabolism via lipooxygenases lox 0.4610583245274275 0.5634425708837468 0.5731335556987549 1.0 1.0 7 Q15067,O15254 2 |
| Mitochondrial complex ii assembly 0.7322053675612403 0.5618817535301716 0.5741965862635112 1.0 1.0 2 P21912 1 |
| Wnt signaling pathway 0.482307741198144 0.5617508493108346 0.5742857840098741 1.0 1.0 13 P48729,P61586,P42345 3 |
| Hippo signaling regulation pathways 0.4991515936811146 0.5575210161559769 0.5771715041835599 1.0 1.0 18 P19022,P61586,P42345 3 |
| Ethanol metabolism production of ros by cyp2e1 0.7211201866977861 0.5276715290808958 0.5977273373190888 1.0 1.0 2 P36507 1 |
| Mthfr deficiency 0.4535111344638676 0.5167065305693778 0.6053610365768922 1.0 1.0 8 Q7L592,P21964,P26358 3 |
| Pi3kaktmtor signaling pathway and therapeutic opportunities 0.5024212358241708 0.5131137670590942 0.6078717418722519 1.0 1.0 4 P42345 1 |
| 15q112 copy number variation syndrome 0.5020974757295509 0.5119394088845062 0.6086934160148323 1.0 1.0 4 Q7L576 1 |
| Cholesterol biosynthesis pathway 0.4687270362863778 0.5058005717282956 0.6129966571287921 1.0 1.0 13 Q01581,Q16850,Q15800,P37268 4 |
| Familial partial lipodystrophy fpld 0.4451549731195834 0.4970479001866474 0.6191552732612329 1.0 1.0 7 O75844 1 |
| Kennedy pathway from sphingolipids 0.4971735133124336 0.494177678257943 0.6211807026539158 1.0 1.0 4 O95470 1 |
| Sphingolipid pathway 0.4476176588994727 0.4924610105206043 0.6223934782531926 1.0 1.0 8 O95470,Q96G23 2 |
| Cholesterol metabolism with bloch and kandutschrussell pathways 0.5068849037113662 0.4896107935183971 0.6244093372273205 1.0 1.0 25 P35610,P37268,Q16850,Q15800,Q01581,Q15392,Q9BWD1 7 |
| Ferroptosis 0.4927395741821299 0.4615141181921539 0.6444297946672566 1.0 1.0 23 P16435,P09601,P37268,P45880,O95352,Q15366,P08195 7 |
| Electron transport chain oxphos system in mitochondria 0.5876532110640514 0.4490774991534695 0.6533757514217764 1.0 1.0 52 O75880,P14927,O75306,O95299,P47985,P14406,P00403,P20674,O75964,P22695,P21912,P31930,P13073,O00217,O43676,P12236,P12235,P24539,O75489,O96000,Q9UII2,P06576,P05141,P14854,Q9UDW1,P51970,Q9Y6M9,P25705 28 |
| Hostpathogen interaction of human coronaviruses mapk signaling 0.4357704224004211 0.4446727861977534 0.656556238638303 1.0 1.0 8 Q15418,P36507,P51812 3 |
| Biomarkers for pyrimidine metabolism disorders 0.4302431770358448 0.436810397569805 0.6622488578096375 1.0 1.0 7 P04818,Q9Y606,P23921,Q9H0P0,P12277 5 |
| Urea cycle and related diseases 0.6840723453908824 0.4196835910286957 0.6747166138249414 1.0 1.0 2 Q9UJS0 1 |
| Base excision repair 0.458433369512817 0.4098337039644633 0.6819279403755969 1.0 1.0 17 P27695,Q9Y2S7,Q07864 3 |
| Burn wound healing 0.4265390254637307 0.3948381257644595 0.6929623558853895 1.0 1.0 9 P42574,P31949,P09429,P50454,P07737 5 |
| Sphingolipid metabolism integrated pathway 0.4134006878449683 0.3715418106450069 0.7102340205398023 1.0 1.0 7 O95470,Q96G23 2 |
| Sphingolipid metabolism overview 0.4134006878449683 0.3715418106450069 0.7102340205398023 1.0 1.0 7 O95470,Q96G23 2 |
| Arachidonate epoxygenase epoxide hydrolase 0.6595682613768943 0.354385696500748 0.7230498524673155 1.0 1.0 2 P20674 1 |
| Nanoparticle triggered regulated necrosis 0.6584014002333776 0.3514106106088611 0.7252803232598071 1.0 1.0 2 P09874 1 |
| Epo receptor signaling 0.4135810891561154 0.3461698978100402 0.7292150358539782 1.0 1.0 9 Q15118,P42224,P36507 3 |
| Vitamin b6dependent and responsive disorders 0.4986514685480596 0.3372301131129987 0.7359434384858845 1.0 1.0 3 Q9UDR5 1 |
| Pdgf pathway 0.4284596306567977 0.3248925829917833 0.745262370564753 1.0 1.0 15 P42224,P00403,P61586 3 |
| Myd88 distinct inputoutput pathway 0.6455659276546154 0.3195342096607808 0.7493214543717059 1.0 1.0 2 P51617 1 |
| Interleukin1 induced activation of nfkb 0.6455659276546154 0.3195342096607808 0.7493214543717059 1.0 1.0 2 P51617 1 |
| Thyroid stimulating hormone tsh signaling pathway 0.4389556786241216 0.3017476331591495 0.7628444537066259 1.0 1.0 20 Q15418,P27695,P62753,P42345 4 |
| Nitric oxide metabolism in cystic fibrosis 0.4387040280210221 0.3002698492207767 0.7639713295463746 1.0 1.0 4 O14744,Q86X55,Q99873 3 |
| Il5 signaling pathway 0.411962512725517 0.2911989051574336 0.7708991998670516 1.0 1.0 13 Q15418,P42224,P62753 3 |
| Follicle stimulating hormone fsh signaling pathway 0.3929643810039586 0.284962720448485 0.7756727030469062 1.0 1.0 8 P62753 1 |
| Sarscov2 innate immunity evasion and cellspecific immune response 0.400423271493506 0.2752040570401263 0.783159470206805 1.0 1.0 11 Q14258,P42224,O43747,P35613 4 |
| Hematopoietic stem cell gene regulation by gabp alphabeta complex 0.3746982452382319 0.246506449312105 0.8052902126204391 1.0 1.0 6 Q13315 1 |
| Wnt signaling 0.4104147421001633 0.2407677568395529 0.8097351208801316 1.0 1.0 17 P48729,P63000,P61586 3 |
| Regulation of apoptosis by parathyroid hormonerelated protein 0.3984599064049816 0.2403730557305606 0.8100410643584226 1.0 1.0 5 Q9BXK5 1 |
| Pi3kaktmtor vitd3 signaling 0.3956384412638143 0.232117224495612 0.8164469669792456 1.0 1.0 5 P42345 1 |
| Netrinunc5b signaling pathway 0.397551645478832 0.221508965133283 0.8246961568040014 1.0 1.0 15 P42574,Q8TCG1,P36507,P63000,P61586 5 |
| Head and neck squamous cell carcinoma 0.3909581225959742 0.2115666424592474 0.8324451356610116 1.0 1.0 14 P54646,P62753,P42345 3 |
| Selenium micronutrient network 0.3858593081885581 0.2063096677857731 0.8365490271776419 1.0 1.0 13 Q8WTV0,Q13162 2 |
| Intraflagellar transport proteins binding to dynein 0.3684352787203808 0.2048556965032825 0.8376848701379942 1.0 1.0 8 Q8NCM8,Q9Y6G9 2 |
| Chromosomal and microsatellite instability in colorectal cancer 0.396525585985163 0.1977711056379219 0.8432241539852516 1.0 1.0 17 P42574,Q96KP1,P48729,P63000,P61586,Q04864 6 |
| Type ii diabetes mellitus 0.3819180099187819 0.1936329499497003 0.8464632961214564 1.0 1.0 5 P42345 1 |
| Genes controlling nephrogenesis 0.3643263399928274 0.1923915176445805 0.8474355362318529 1.0 1.0 8 P11047,O94813 2 |
| Leukocyteintrinsic hippo pathway functions 0.3640052917131139 0.1914298165927221 0.8481888617305828 1.0 1.0 8 P61586 1 |
| Extracellular vesiclemediated signaling in recipient cells 0.3795444375750915 0.1872636869230371 0.851453892941586 1.0 1.0 5 P42345 1 |
| Nonalcoholic fatty liver disease 0.5176475795237734 0.1866261531140327 0.8519537597795153 1.0 1.0 55 P42574,P14927,O75306,O95299,P08574,P14406,Q9P0J0,P00403,P20674,P54646,P49327,P22695,P21912,Q96GC9,P63000,P13073,O00217,O43676,O75489,Q86Y39,P14854,Q07812,Q9UDW1,Q9Y6M9,P51970 25 |
| Transsulfuration and onecarbon metabolism 0.3990217032524859 0.185318486439932 0.8529792390773632 1.0 1.0 19 P04818,O43865,P34897,P13995,P00374,P26358 6 |
| Pancreatic adenocarcinoma pathway 0.416460135359013 0.1778030405266077 0.8588776594050092 1.0 1.0 25 P30086 1 |
| Bdnftrkb signaling 0.358248371768271 0.1744895891228743 0.861480711939967 1.0 1.0 8 Q15418 1 |
| Onecarbon metabolism and related pathways 0.3781087015172865 0.1734189879275182 0.8623221010162476 1.0 1.0 14 P04818,P34897,O15382 3 |
| Photodynamic therapyinduced hif1 survival signaling 0.3662360134686921 0.1683621691137658 0.8662983679020484 1.0 1.0 11 P53985,Q07812 2 |
| Hair follicle development organogenesis part 2 of 3 0.3884997081144258 0.1662557423144952 0.8679556937628883 1.0 1.0 4 P13591,P05556,Q9BZE4 3 |
| Nephrotic syndrome 0.3728485544398369 0.1586015721120539 0.8739827901090844 1.0 1.0 14 Q9BT22,O75844,Q86YH6 3 |
| Fatty acid transporters 0.3675061444769213 0.1563217813243266 0.8757793883763032 1.0 1.0 5 Q01469 1 |
| Mapk pathway in congenital thyroid cancer 0.3789058313215441 0.1447813295634421 0.8848835237427806 1.0 1.0 4 P36507 1 |
| Il9 signaling pathway 0.3476338958273162 0.1358367622691147 0.8919503283097483 1.0 1.0 9 P42224,P36507,Q02750 3 |
| Leptininsulin signaling overlap 0.5414235705951096 0.1247211609070277 0.9007443042272508 1.0 1.0 2 O14654 1 |
| Canonical and noncanonical notch signaling 0.3991829588561513 0.1150399072888914 0.9084134905640198 1.0 1.0 3 Q04721,O15111 2 |
| Regucalcin in proximal tubule epithelial kidney cells 0.33483851180936 0.1118025368831213 0.9109799759955126 1.0 1.0 8 P42574,Q8NE86,P42345 3 |
| Overlap between signal transduction pathways contributing to lmna laminopathies 0.3613598808765939 0.1111663120137175 0.9114844651345276 1.0 1.0 16 P48729,O75844,O60725 3 |
| Integrated cancer pathway 0.3770357974635623 0.1087659619051194 0.9133881220712592 1.0 1.0 21 P42574,Q13535,P14859,P42224,Q13315,P53350 6 |
| Urea cycle and associated pathways 0.3499712704841423 0.1078509877484571 0.9141138963610008 1.0 1.0 13 Q9UJS0,P32322,O75746,P30038 4 |
| Male infertility 0.3853795364628473 0.1048605481184617 0.916486464364482 1.0 1.0 24 P35251,P08183,Q15165,Q13315 4 |
| Proteasome degradation 0.4415543835143233 0.0977060279222094 0.9221657288732524 1.0 1.0 42 P28074,P20618,P04439,P01889,P04844,P28070,P61289,P28072,P46934,P49721,P60900,P10321 12 |
| Il7 signaling pathway 0.3192348336825406 0.0831493226315073 0.9337328078085212 1.0 1.0 7 P42224,P36507 2 |
| Fluoropyrimidine activity 0.3375672151414289 0.0792495746686434 0.93683411367107 1.0 1.0 13 P00374,Q06203 2 |
| Development of ureteric collection system 0.3307802686232988 0.0766984574972745 0.9388634316667492 1.0 1.0 5 Q13418,O94813 2 |
| Acute viral myocarditis 0.3454617335588328 0.0746160452288896 0.9405202074658964 1.0 1.0 16 P42574,Q14249,P78310,Q07812,P11940,P42224,P09874,Q13418 8 |
| Interferon type i signaling pathways 0.3484129654101335 0.0737809996516273 0.9411846458940863 1.0 1.0 17 P63244,P42345,P42224,Q04864,P62753 5 |
| Thermogenesis 0.3810732737858108 0.0724725495513924 0.9422258502950946 1.0 1.0 27 Q92922,P42345,P23786,Q15418,P62753,O43772 6 |
| Id signaling pathway 0.4894982497083041 0.0710570082664719 0.9433523840715856 1.0 1.0 2 P24941 1 |
| Neurodegeneration with brain iron accumulation nbia subtypes pathway 0.3271379243462224 0.0574542626114649 0.9541833390363704 1.0 1.0 13 O95352,P42345,Q14457 3 |
| Camkk2 pathway 0.3256671044443568 0.0545470966851124 0.956499286687706 1.0 1.0 13 P63000,P09601,P42345 3 |
| Transcription factors regulate mirnas related to cardiac hypertrophy 0.4626604434072562 0.0530975349093648 0.9576541955414472 1.0 1.0 2 P40763 1 |
| P53 transcriptional gene network 0.3111289284554669 0.0524099857830532 0.9582020175495956 1.0 1.0 9 P49327,Q07812,Q709F0 3 |
| Pyrimidine metabolism and related diseases 0.3031712220844378 0.0500631799279313 0.9600720410872576 1.0 1.0 7 P04818 1 |
| Mammary gland development pathway involution stage 4 of 4 0.3405310767435198 0.0457371647368892 0.9635197416153068 1.0 1.0 3 Q07812,P40763 2 |
| Tca cycle in senescence 0.2995324371712479 0.0372108241991149 0.9703169081277574 1.0 1.0 8 P23368,P07954,P17174,P08559,P48163,Q15118,P04637 7 |
| Serotonin and anxiety 0.4232788798133133 0.0361673185376711 0.9711489449605346 1.0 1.0 2 P05771 1 |
| Thymic stromal lymphopoietin tslp signaling pathway 0.3099459524329376 0.0317767793735907 0.9746500646583344 1.0 1.0 12 P62753,P42345 2 |
| Energy metabolism 0.3065223749634257 0.0317083575571942 0.9747046298726229 1.0 1.0 11 P54646,Q15648,Q9H5Q4,Q96EB6,Q13555,P54619,Q13547,Q99873,Q00059,Q8WVM0 10 |
| Ncrnas involved in wnt signaling in hepatocellular carcinoma 0.3027600516335857 0.0310642938084988 0.9752182653311756 1.0 1.0 10 Q86UE4 1 |
| Hedgehog signaling pathway wp4249 0.2838785046729033 0.022372148446182 0.9821510971099534 1.0 1.0 6 Q13618,P48729,P32121,P17612,Q9Y496 5 |
| Mammary gland development pathway embryonic development stage 1 of 4 0.3214702450408353 0.0222645497755886 0.9822369270489592 1.0 1.0 2 P05556 1 |
| Phosphoinositides metabolism 0.2929128367779262 0.0204761202718109 0.9836635613451494 1.0 1.0 9 Q8TBX8,Q01968,Q9Y217,Q99570,O00443 5 |
| 4hydroxytamoxifen dexamethasone and retinoic acids regulation of p27 expression 0.2875939099507562 0.0175141802854539 0.9860264203499044 1.0 1.0 8 P36507,P42345 2 |
| Fgfr3 signaling in chondrocyte proliferation and terminal differentiation 0.281011425969969 0.0127782935376496 0.9898046743305852 1.0 1.0 7 P42224,P36507 2 |
| Dna mismatch repair 0.3176842899431703 0.0061355331318786 0.9951045835562672 1.0 1.0 19 P40937,P35251,Q9Y2S7,Q07864 4 |
| Nrf2 pathway 0.323076406244512 0.0039949096611448 0.996812531737868 1.0 1.0 21 O15217 1 |
| Photodynamic therapyinduced ap1 survival signaling 0.2723963809779687 0.000823917593488 0.9993426089471592 1.0 1.0 7 P49327 1 |
| Sterol regulatory elementbinding proteins srebp signaling 0.3549070367850427 0.000606803899763 0.9995158405666562 1.0 1.0 31 P54646,Q8WTV0,P37268,Q16850,P42345,Q01581 6 |
|
|
